Development of virus-like particles with inbuilt immunostimulatory properties as vaccine candidates

The development of virus-like particle (VLP) based vaccines for human papillomavirus, hepatitis B and hepatitis E viruses represented a breakthrough in vaccine development. However, for dengue and COVID-19, technical complications, such as an incomplete understanding of the requirements for protecti...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Simon Collett, Linda Earnest, Julio Carrera Montoya, Melissa A. Edeling, Ashley Yap, Chinn Yi Wong, Dale Christiansen, Jason Roberts, Jamie Mumford, Valerie Lecouturier, Vincent Pavot, Sergio Marco, Joon Keit Loi, Cameron Simmons, Shivali A. Gulab, Jason M. Mackenzie, Aaron Elbourne, Paul A. Ramsland, Garth Cameron, Dhiraj Hans, Dale I. Godfrey, Joseph Torresi
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2023-06-01
coleção:	Frontiers in Microbiology
Assuntos:	flavivirus arbovirus adjuvant VLP immunology SARS-CoV-2
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fmicb.2023.1065609/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!